Synthesis and in vitro anticancer evaluation of 1,4-phenylene-bis-pyrimidine-2-amine derivatives
   
Yazarlar (5)
Prof. Dr. Meliha Burcu GÜRDERE Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Erdoğan Kamo Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Ayşe Şahin Yağlıoğlu Çankırı Karatekin Üniversitesi, Türkiye
Prof. Dr. Yakup BUDAK Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Prof. Dr. Mustafa CEYLAN Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Makale Türü Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı TURKISH JOURNAL OF CHEMISTRY (Q4)
Dergi ISSN 1300-0527 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili İngilizce Basım Tarihi 01-2017
Cilt / Sayı / Sayfa 41 / 2 / 263–271 DOI 10.3906/kim-1603-112
Makale Linki http://online.journals.tubitak.gov.tr/openDoiPdf.htm?mKodu=kim-1603-112
Özet
A series of 1, 4-phenylene-bis-chalcones 3a-3h were synthesized by the reaction of terephthalaldehyde with substituted arylketones in this study. The novel 1, 4-phenylene-bis-pyrimidine-2-amine derivatives 5a-5h were obtained by the addition of guanidine hydrochloride to 1, 4-phenylene-bis-chalcone 3a-3h in ethanolic KOH under reflux conditions. The structure of the compounds was explained by means of IR, H NMR, C NMR, and elemental analyses. The anticancer activities of 3a-3h and 5a-5h were investigated against rat brain tumor cells and human uterus carcinoma in vitro Activity tests were performed as dose-dependent assays at eight concentrations. The positive control was 5-fluorouracil (5-FU). Compounds 3c and 3d were examined and they showed high activities as compared to 5-FU against C6 (rat brain tumor) and HeLa (human uterus carcinoma) cells. The anticancer activity of 5h was better than that of 5-FU at high concentrations cell-selectively against C6 cells.
Anahtar Kelimeler
1,4-Phenylene-bis-chalcone | 1,4-phenylene-bis-pyrimidine | HeLa | C6 | anticanceractivity | 5-fluorouracil
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları
Google Scholar 13
Web of Science 10
Synthesis and in vitro anticancer evaluation of 1,4-phenylene-bis-pyrimidine-2-amine derivatives

Paylaş